Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentmicrotubule associated complex

KATNBL1 KIF1C

2.05e-0316192GO:0005875
DomainFHA

CEP170 KIF1C

7.75e-052892SM00240
DomainFHA_DOMAIN

CEP170 KIF1C

9.53e-053192PS50006
DomainFHA

CEP170 KIF1C

9.53e-053192PF00498
Domain-

CEP170 KIF1C

1.29e-0436922.60.200.20
DomainFHA_dom

CEP170 KIF1C

1.29e-043692IPR000253
DomainSMAD_FHA_domain

CEP170 KIF1C

2.70e-045292IPR008984
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CEP170 CDK17 HIVEP2 KIF1C

4.26e-058619436931259
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

CEP170 CDK17 ZC3H4 KIF1C

1.33e-0411559420360068
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

CEP170 KATNBL1 ZC3H4

1.39e-044209328065597
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

CEP170 CDK17 KIF1C

1.66e-044469324255178
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

CEP170 CDK17 HIVEP2 ZC3H4

1.16e-0546694M13522
CoexpressionZHENG_FOXP3_TARGETS_IN_THYMUS_UP

CDK17 FLI1 HIVEP2

3.50e-0519993M1746
CoexpressionZHENG_FOXP3_TARGETS_IN_THYMUS_UP

CDK17 FLI1 HIVEP2

3.55e-0520093MM1033
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

CEP170 HIVEP2 ZC3H4

1.18e-0430093M8702
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

CEP170 CDK17 HIVEP2 ZC3H4

1.25e-0485694M4500
CoexpressionRODRIGUES_THYROID_CARCINOMA_DN

KATNBL1 HIVEP2

3.10e-047892M9814
CoexpressionSENESE_HDAC3_TARGETS_UP

CEP170 CDK17 HIVEP2

5.17e-0449593M8451
CoexpressionZHENG_BOUND_BY_FOXP3

CDK17 FLI1 HIVEP2

5.26e-0449893M1741
CoexpressionZHENG_BOUND_BY_FOXP3

CDK17 FLI1 HIVEP2

5.54e-0450793MM1030
CoexpressionAZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP

CDK17 FLI1

8.07e-0412692M2309
CoexpressionBYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS

FLI1 KIF1C

8.99e-0413392M8699
CoexpressionBYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS

FLI1 KIF1C

1.04e-0314392MM609
CoexpressionBENPORATH_NOS_TARGETS

CDK17 KATNBL1

1.62e-0317992M14573
CoexpressionGSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP

ZC3H4 KIF1C

1.64e-0318092M357
CoexpressionGSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP

CEP170 ZC3H4

1.88e-0319392M7943
CoexpressionGSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP

CDK17 HIVEP2

1.93e-0319692M8858
CoexpressionGSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN

CDK17 HIVEP2

1.95e-0319792M6835
CoexpressionGSE16266_CTRL_VS_LPS_STIM_MEF_UP

CEP170 CDK17

1.97e-0319892M7219
CoexpressionGSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP

FLI1 HIVEP2

1.97e-0319892M4408
CoexpressionGSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP

CEP170 CDK17

1.99e-0319992M8396
CoexpressionGSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP

CEP170 CDK17

1.99e-0319992M8381
CoexpressionGSE3982_MAC_VS_NKCELL_UP

CEP170 KIF1C

1.99e-0319992M5508
CoexpressionGSE22886_NAIVE_VS_MEMORY_TCELL_DN

FLI1 HIVEP2

1.99e-0319992M4417
CoexpressionGSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN

CDK17 HIVEP2

1.99e-0319992M6837
CoexpressionGSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN

FLI1 HIVEP2

1.99e-0319992M4407
CoexpressionGSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN

CDK17 FLI1

1.99e-0319992M8065
CoexpressionGSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP

FLI1 ZC3H4

1.99e-0319992M3262
CoexpressionGSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP

KATNBL1 KIF1C

2.01e-0320092M3968
CoexpressionGSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP

CDK17 HIVEP2

2.01e-0320092M9881
CoexpressionGSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP

CEP170 HIVEP2

2.01e-0320092M8310
CoexpressionGSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP

CEP170 HIVEP2

2.01e-0320092M8312
CoexpressionGSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN

CDK17 FLI1

2.01e-0320092M5271
CoexpressionGSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN

CDK17 HIVEP2

2.01e-0320092M8327
CoexpressionGSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP

UBTFL1 KATNBL1

2.01e-0320092M8112
CoexpressionGSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN

FLI1 HIVEP2

2.01e-0320092M9688
CoexpressionGSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP

HIVEP2 KIF1C

2.01e-0320092M7981
CoexpressionGSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN

FLI1 HIVEP2

2.01e-0320092M6894
CoexpressionGSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP

FLI1 HIVEP2

2.01e-0320092M9737
CoexpressionGSE369_SOCS3_KO_VS_WT_LIVER_DN

CDK17 HIVEP2

2.01e-0320092M5963
CoexpressionGSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP

CEP170 HIVEP2

2.01e-0320092M6842
CoexpressionGSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN

ZC3H4 KIF1C

2.01e-0320092M4664
CoexpressionGSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP

CEP170 CDK17

2.01e-0320092M8030
CoexpressionGSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP

CEP170 HIVEP2

2.01e-0320092M8290
CoexpressionGSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP

KATNBL1 KIF1C

2.01e-0320092M3860
CoexpressionGSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN

CDK17 HIVEP2

2.01e-0320092M5679
CoexpressionGSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP

CEP170 FLI1

2.01e-0320092M9847
CoexpressionGSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN

CEP170 CDK17

2.01e-0320092M6941
CoexpressionGSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN

CEP170 KATNBL1

2.01e-0320092M3469
CoexpressionGSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN

CEP170 KATNBL1

2.01e-0320092M3450
CoexpressionAtlasdev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000

CEP170 CDK17 FLI1 KATNBL1 HIVEP2 KIF1C

9.24e-0883186gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlasdev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000

CDK17 FLI1 KATNBL1 HIVEP2 KIF1C

7.17e-0757085gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000
CoexpressionAtlasdev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000

CDK17 FLI1 HIVEP2 KIF1C

1.35e-0481784gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000
CoexpressionAtlasdev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000

CDK17 FLI1 KATNBL1 KIF1C

1.55e-0484784gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000

CEP170 CDK17 FLI1

2.32e-0434983DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000
CoexpressionAtlasdev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_500

CDK17 FLI1 KIF1C

3.83e-0441483gudmap_dev gonad_e11.5_M_ReproVasc_Flk_500
CoexpressionAtlasdev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500

CDK17 FLI1 KIF1C

3.86e-0441583gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500
CoexpressionAtlasdev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000

CDK17 FLI1 HIVEP2

4.70e-0444483gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000
CoexpressionAtlasdev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000

CDK17 FLI1 KIF1C

7.21e-0451483gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_1000
CoexpressionAtlasdev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000

CDK17 FLI1 KATNBL1

7.59e-0452383gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

4.12e-0415492e51a5114f0ec38f997f5b8bbf3a7770f98595474
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

4.12e-04154921899138c096c08d8aee6b1970b7c0081e14c88a8
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

CDK17 HIVEP2

4.23e-04156921545169694f686d28648a68b552c2ae606599d66
ToppCellCD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

CEP170 HIVEP2

4.34e-04158925ae737757a49fc96bde1e57e02066f9f65654ea1
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP170 HIVEP2

5.32e-0417592f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCellIIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster

CDK17 FLI1

5.44e-0417792fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCellCOVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

5.56e-04179922a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

5.56e-04179921ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

5.81e-04183924759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

5.81e-0418392dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLI1 KIF1C

6.00e-0418692bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCellCOVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.07e-041879240ffc06a3e3251d9b12da390210d3e045af7537a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.13e-0418892c2c51c6526defe2600302901159b8abbb58d7595
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

CDK17 FLI1

6.20e-041899275c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

CDK17 FLI1

6.20e-0418992c81787a8c662db5d7814c583dd64562857629e81
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.26e-04190921519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCellCOVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.26e-0419092a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCellCOVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.33e-0419192d35aa842b813ea0eff7362abc894cca4e86b2fb2
ToppCellRA-09._Endothelium_I|World / Chamber and Cluster_Paper

CDK17 FLI1

6.33e-0419192c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.33e-0419192b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 HIVEP2

6.39e-04192928b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCellCOVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.46e-0419392479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.46e-04193921f978e102a029a6beb10913052cd0a20c7253e8e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.53e-0419492a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.53e-0419492b0c15e7e4bcf30856fb628dedd7ba82df33489f5
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CEP170 FLI1

6.53e-0419492663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.59e-0419592d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.59e-0419592818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCellCOVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.59e-0419592a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCellCOVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.59e-041959250a193475db1bb1e05b8590225a553688c372c14
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.59e-04195926bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-04196928f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-0419692145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-0419692e224338490691d92c1f70b57112fabdcc92b06a9
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-04196927cbb19108b4553ef60ef5c230a29de1662c02efe
ToppCellCOVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.66e-0419692b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCellbackground-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

CDK17 FLI1

6.66e-0419692e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-0419692b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-04196924cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-0419692d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.66e-0419692d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.73e-04197922844dbcd0a673ed81c99920aa45858651a00736d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CDK17 FLI1

6.73e-0419792c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCellControl_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

CDK17 FLI1

6.80e-04198923c3a5d2555f6af4aa33f9ea778808315d0e39d86
ToppCellCOVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.80e-04198928689090bce9ab6e8f122426a404037e572c6713b
ToppCellASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

CDK17 FLI1

6.80e-0419892e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCellCOVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.80e-041989245419f2804b4be79bae6632e71c54e1af482d115
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster

CEP170 HIVEP2

6.87e-0419992f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCellfacs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CDK17 FLI1

6.87e-0419992c11e0044d3cc37f6bb26df033ad4448b419addfc
ToppCellCOVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.87e-0419992793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster

CEP170 HIVEP2

6.87e-0419992e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCellCOVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type

CDK17 FLI1

6.87e-0419992fffd2f9042b55531dac4e5b463b5cee80402e7bb
ToppCellNeuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster

CEP170 HIVEP2

6.87e-0419992058373b4ac3cec2108cb24265628ff0a50646e33
ToppCellASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

CDK17 FLI1

6.87e-04199920bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type.

CEP170 HIVEP2

6.93e-042009284e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster

CEP170 HIVEP2

6.93e-0420092db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type.

CEP170 HIVEP2

6.93e-0420092c248233b004f8ef0bab3c65ecfe295887966f2ee
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FLI1 HIVEP2

6.93e-04200922d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster

CEP170 HIVEP2

6.93e-042009230a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
DrugZardaverine [101975-10-4]; Up 200; 15uM; PC3; HT_HG-U133A

FLI1 KIF1C MUC7

2.96e-05187834209_UP
DrugSulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A

FLI1 HIVEP2 KIF1C

3.31e-05194836090_DN
DrugBaclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A

FLI1 HIVEP2 KIF1C

3.51e-05198835414_UP
Drugifosfamide

FLI1 MUC7

2.36e-046782CID000003690
DrugFlavonoids

CEP170 HIVEP2 KIF1C MUC7

3.67e-04113684ctd:D005419
Drugirinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A

CDK17 HIVEP2

1.52e-03171827535_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

CDK17 HIVEP2

1.54e-03172824344_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.54e-03172826439_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.54e-03172827073_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.56e-03173824565_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.58e-03174827105_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ZC3H4 KIF1C

1.58e-03174821659_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.60e-03175826736_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.60e-03175825908_DN
DrugSAHA; Down 200; 10uM; HL60; HT_HG-U133A

FLI1 ZC3H4

1.60e-03175821161_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.60e-03175826316_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

HIVEP2 ZC3H4

1.61e-03176821535_DN
DrugSAHA; Down 200; 10uM; HL60; HT_HG-U133A

FLI1 ZC3H4

1.61e-03176826179_DN
DrugSAHA; Down 200; 10uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.65e-03178824444_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.65e-03178825086_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A

FLI1 ZC3H4

1.67e-03179821175_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.67e-03179826609_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.67e-03179824483_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.69e-03180821793_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.69e-03180825981_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

CDK17 ZC3H4

1.69e-03180824541_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.71e-03181827077_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

CDK17 ZC3H4

1.72e-03182823887_DN
DrugAlsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A

CDK17 ZC3H4

1.76e-03184827056_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.76e-03184827555_DN
Drugtyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA

CDK17 ZC3H4

1.78e-03185821114_DN
Drug0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A

HIVEP2 ZC3H4

1.78e-03185824755_DN
DrugSanguinarine [2447-54-3]; Up 200; 12uM; MCF7; HT_HG-U133A

FLI1 KIF1C

1.78e-03185824168_UP
DrugMonensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A

CDK17 FLI1

1.82e-03187827402_DN
DrugDexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

HIVEP2 KIF1C

1.84e-03188822079_DN
DrugDoxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A

CDK17 ZC3H4

1.84e-03188823291_DN
DrugAlsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A

CDK17 ZC3H4

1.84e-03188827078_DN
DrugH-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A

HIVEP2 ZC3H4

1.86e-03189825936_DN
DrugEburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A

HIVEP2 KIF1C

1.88e-03190827154_DN
DrugMethotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A

CDK17 HIVEP2

1.88e-03190826318_DN
DrugLidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A

FLI1 KIF1C

1.88e-03190824421_DN
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

1.90e-03191826024_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

1.90e-03191827503_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

CDK17 FLI1

1.92e-03192824268_DN
Drugdeferoxamine mesylate salt; Up 200; 100uM; MCF7; HG-U133A

HIVEP2 KIF1C

1.92e-0319282485_UP
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

FLI1 KIF1C

1.94e-03193824338_DN
DrugTriamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A

FLI1 KIF1C

1.94e-03193822078_UP
DrugButoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

FLI1 HIVEP2

1.96e-03194823288_UP
DrugBetazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A

CDK17 FLI1

1.96e-03194821812_UP
DrugAndrosterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

1.96e-03194822650_DN
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A

KIF1C MUC7

1.96e-03194823785_UP
DrugBambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A

CDK17 FLI1

1.98e-03195821582_DN
DrugDelcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A

FLI1 HIVEP2

1.98e-03195824737_DN
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A

FLI1 KIF1C

1.98e-03195825401_UP
DrugLY 294002; Down 200; 10uM; PC3; HT_HG-U133A

FLI1 KIF1C

1.98e-03195821239_DN
DrugBetonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A

FLI1 KIF1C

1.98e-03195826063_UP
DrugProadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A

CDK17 KIF1C

1.98e-03195822707_DN
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A

CDK17 FLI1

1.98e-03195825427_DN
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; HL60; HG-U133A

CDK17 FLI1

2.00e-03196821433_DN
DrugSuramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

2.00e-03196827496_DN
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A

CDK17 HIVEP2

2.00e-03196822108_DN
DrugCimetidine [51481-61-9]; Down 200; 15.8uM; HL60; HG-U133A

CDK17 FLI1

2.00e-03196821964_DN
DrugPizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A

FLI1 HIVEP2

2.00e-03196825072_DN
Drugcox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A

CDK17 KIF1C

2.00e-0319682253_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A

FLI1 HIVEP2

2.00e-03196821861_DN
DrugPNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A

KIF1C MUC7

2.00e-03196823692_UP
DrugGSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A

HIVEP2 KIF1C

2.00e-03196827092_UP
DrugChlorphensin carbamate [886-74-8]; Down 200; 16.2uM; HL60; HG-U133A

CDK17 FLI1

2.00e-03196821432_DN
DrugChrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

2.00e-03196827139_DN
DrugDiethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A

FLI1 KIF1C

2.00e-03196824547_UP
DrugImipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A

HIVEP2 KIF1C

2.00e-03196821849_UP
DrugCarbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; PC3; HT_HG-U133A

CDK17 MUC7

2.02e-03197827138_UP
DrugMolindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A

KIF1C MUC7

2.02e-03197824199_UP
DrugAcetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A

FLI1 HIVEP2

2.02e-03197823364_DN
DrugEnoxacin [74011-58-8]; Up 200; 12.4uM; HL60; HG-U133A

CDK17 FLI1

2.02e-03197821597_UP
DrugEthamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A

CDK17 FLI1

2.02e-03197827260_UP
DrugHexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A

FLI1 KIF1C

2.02e-03197826077_DN
DrugLevamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HG-U133A

CDK17 FLI1

2.02e-03197821410_DN
DrugXamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A

FLI1 HIVEP2

2.02e-03197823401_DN
DrugAtropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A

FLI1 KIF1C

2.02e-03197822761_UP
DrugRoxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A

KIF1C MUC7

2.02e-03197824192_UP
DrugMorantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A

HIVEP2 ZC3H4

2.02e-03197821798_DN
DrugIdoxuridine [54-42-2]; Down 200; 11.2uM; HL60; HG-U133A

CDK17 FLI1

2.02e-03197821980_DN
DrugOrlistat; Up 200; 10uM; MCF7; HT_HG-U133A

CDK17 KIF1C

2.02e-03197826383_UP
DrugMonensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A

HIVEP2 KIF1C

2.02e-03197823443_DN
DrugArecoline hydrobromide [300-08-3]; Up 200; 17uM; PC3; HT_HG-U133A

FLI1 KIF1C

2.02e-03197826322_UP
DrugOfloxacin [82419-36-1]; Down 200; 11uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

2.02e-03197822302_DN
DrugSaquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A

HIVEP2 KIF1C

2.02e-03197823549_DN
DrugNifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

2.02e-03197822285_DN
DrugMerbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A

CDK17 HIVEP2

2.02e-03197823439_DN
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A

CDK17 FLI1

2.02e-03197821386_DN
DrugBrompheniramine maleate [980-71-2]; Up 200; 9.2uM; PC3; HT_HG-U133A

KIF1C MUC7

2.04e-03198824013_UP
DrugTriprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A

FLI1 KIF1C

2.04e-03198827008_UP
Diseaselean body mass

HIVEP2 ZC3H4

5.58e-0337992EFO_0004995
Diseaseeosinophil count

CDK17 FLI1 HIVEP2

8.55e-03148893EFO_0004842
Diseasevisceral adipose tissue measurement

HIVEP2 ZC3H4

8.85e-0348192EFO_0004765
Diseasehemoglobin A1 measurement

ZC3H4 KIF1C

1.03e-0252092EFO_0007629

Protein segments in the cluster

PeptideGeneStartEntry
PPKQKSSPVNNHHSP

CEP170

1516

Q5SW79
HHPFPNPCYRKKQSP

KATNBL1

76

Q9H079
AQPEPQHFQPKKHNS

KIF1C

1046

O43896
QHFQPKKHNSYPQPP

KIF1C

1051

O43896
KKHNSYPQPPQPYPA

KIF1C

1056

O43896
NFPKYKPQPLINHAP

CDK17

426

Q00537
NPHQPPKHPDKNSSV

MUC7

86

Q8TAX7
YHAHQQKVNFVPPHP

FLI1

391

Q01543
PQKPPMNGYHKFHQD

UBTFL1

221

P0CB47
HQQYPPSHATPLPKK

ZC3H4

166

Q9UPT8
PHPFAQHPQKSYGKP

HIVEP2

1231

P31629